Deupirfenidone

N/A

Report date: 2026/05/15 09:42:37
NME

Base Information

Drug NameDeupirfenidone
Drug Alias NameDeuterated pirfenidonePirfenidone deuteratedDeuterium-substituted pirfenidoneSD-560LYT-100
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Deuterated drugs
Mechanisms of ActionCytokines inhibitorsCollagen inhibitorsTransforming growth factor beta inhibitors
TargetsCollagenCytokinesTransforming growth factor beta
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)LymphedemaIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUkraineThailand +[20] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaIND
Originator CompaniesTeva Pharmaceutical Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPureTech LYT 100 IncPuretech Health
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Lymphedema

Other Information

ATC CodeN/A
Related LinksN/A